Trial intelligence / Profile preview

Celecoxib in Knee Osteoarthritis

NCT00597415Phase 2Unknown

Sponsor
University Hospitals Cleveland Medical Center
Start
Dec 2004
Primary completion
Feb 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in osteoarthritis (OA) comparing Placebo with Celecoxib (2 arms). Primary endpoint: Time to onset of moderate and severe pain. Status: unknown.

02

Drugs

celecoxib
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT00597415.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00597415.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call